T
61.37
-3.85 (-5.90%)
| Previous Close | 65.22 |
| Open | 66.26 |
| Volume | 15,431,689 |
| Avg. Volume (3M) | 13,203,004 |
| Market Cap | 10,624,129,024 |
| Price / Sales | 12.36 |
| Price / Book | 162.47 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 19 Aug 2025 |
| Profit Margin | -101.79% |
| Operating Margin (TTM) | -25.33% |
| Diluted EPS (TTM) | -6.23 |
| Quarterly Revenue Growth (YOY) | 35.80% |
| Total Debt/Equity (MRQ) | 830.85% |
| Current Ratio (MRQ) | 2.29 |
| Operating Cash Flow (TTM) | -189.04 M |
| Levered Free Cash Flow (TTM) | 82.42 M |
| Return on Assets (TTM) | -57.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Tempus AI, Inc. | Bullish | - |
AIStockmoo Score
-1.2
| Analyst Consensus | -1.5 |
| Insider Activity | -4.0 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -1.20 |
|
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 44.55% |
| % Held by Institutions | 34.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Softbank Group Corp. | 31 Dec 2024 | 5,405,406 |
| Revolution Growth Management Company, Inc. | 31 Dec 2024 | 3,467,565 |
| Frontier Capital Management Co Llc | 31 Dec 2024 | 943,718 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 70.00 (Needham, 14.06%) | Buy |
| Median | 60.00 (-2.23%) | |
| Low | 55.00 (Piper Sandler, -10.38%) | Hold |
| 55.00 (JP Morgan, -10.38%) | Hold | |
| Average | 60.83 (-0.88%) | |
| Total | 3 Buy, 3 Hold | |
| Avg. Price @ Call | 43.01 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 09 May 2025 | 65.00 (5.91%) | Buy | 0.000 |
| 06 Mar 2025 | 60.00 (-2.23%) | Buy | 48.86 | |
| Needham | 07 May 2025 | 70.00 (14.06%) | Buy | 54.29 |
| 24 Apr 2025 | 70.00 (14.06%) | Buy | 53.50 | |
| BTIG | 21 Apr 2025 | 60.00 (-2.23%) | Buy | 40.98 |
| Piper Sandler | 04 Mar 2025 | 55.00 (-10.38%) | Hold | 52.73 |
| B of A Securities | 03 Mar 2025 | 60.00 (-2.23%) | Hold | 50.93 |
| JP Morgan | 25 Feb 2025 | 55.00 (-10.38%) | Hold | 59.10 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| EPSTEIN DAVID R | - | 54.29 | -370 | -20,087 |
| FUKUSHIMA RYAN | - | 54.29 | -20,000 | -1,085,800 |
| Aggregate Net Quantity | -20,370 | |||
| Aggregate Net Value ($) | -1,105,887 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 54.29 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FUKUSHIMA RYAN | Officer | 06 May 2025 | Automatic sell (-) | 20,000 | 54.29 | 1,085,800 |
| EPSTEIN DAVID R | Director | 01 May 2025 | Automatic sell (-) | 370 | 54.29 | 20,087 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |